Sign in to view content

Year 1 Time to Mobility Test Completion in a Voretigene Neparvovec-rzyl Trial in Subjects With RPE65 Mutation–Associated Inherited Retinal Disease

Julia A. Haller, MD

Video
Published 2018

Related

Direct-to-Consumer Marketing by U.S. Cell Therapy Clinics for Retinal Conditions
Ajay E Kuriyan, MD, MS
Annual Meeting Talks
2018
Effect of Fluocinolone Acetonide 0.2µg/day (ILUVIEN®) Implant on the Decision to Drive in Patients With Differential Control of DME
Seenu M. Hariprasad, MD
On Demand Cases, Courses, and Papers
2018
Endophthalmitis Rates After Bilateral Same Day Intravitreal Anti-VEGF Injections
Durga Borkar, MD
Annual Meeting Talks
2018

Category: Inherited retinal diseases

See more